Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Artiva Biotherapeutics, Inc. Common Stock Banner

Artiva Biotherapeutics, Inc. Common Stock

ARTV Stock Analysis

Page title

Section title

Breakdown
2020
2021
2022
2023
Net Income
-17.991m-71.825m-58.788m-28.720m
Depreciation & Amortization
73.000K248.000K1.158M2.266M
Change in Working Capital
4.358M33.413M-3.866m-28.280m
Operating Cash Flow
-13.541m-15.304m-50.829m-47.430m
Capital Expenditure
-284.000k-1.724m-6.299m-3.258m
Free Cash Flow
-13.825m-17.028m-57.128m-50.688m
Debt Repayment
-3.000m0.0000.0000.000
Dividends Paid
0.0000.0000.0000.000
Common Stock Issued
215.000K0.0000.0000.000
Common Stock Repurchased
0.0000.000-5.000k-12.000k
Net Change in Cash
23.570M135.726M-58.392m-49.014m